Key regions: China, Europe, Australia, United States, Germany
The pharmaceutical industry in Algeria has been experiencing steady growth in recent years due to a range of factors. One of the most significant drivers of this growth has been the increasing demand for Other Pharmaceuticals.
Customer preferences: The Algerian population has been showing a growing preference for Other Pharmaceuticals, which includes a wide range of products such as vitamins, supplements, and herbal remedies. This trend is largely driven by an increasing awareness of health and wellness, with many consumers seeking out natural and alternative remedies to traditional pharmaceuticals.
Trends in the market: The Other Pharmaceuticals market in Algeria has been growing steadily in recent years, with a range of new products entering the market. This trend is expected to continue in the coming years, as more consumers seek out natural and alternative remedies for their health needs. Additionally, there has been a growing interest in locally-produced products, which has led to an increase in the number of local manufacturers of Other Pharmaceuticals.
Local special circumstances: One of the key factors driving the growth of the Other Pharmaceuticals market in Algeria is the country's large and growing population. With over 43 million people, Algeria is one of the largest markets in North Africa, and this has attracted a range of international pharmaceutical companies to the country. Additionally, Algeria has a well-established healthcare system, which has helped to support the growth of the pharmaceutical industry in the country.
Underlying macroeconomic factors: The Algerian economy has been growing steadily in recent years, with a range of government initiatives aimed at promoting economic development and diversification. This has helped to create a favorable environment for the pharmaceutical industry, which has been able to take advantage of the country's growing middle class and increasing demand for healthcare products. Additionally, Algeria has a relatively young population, with a median age of just 28 years, which has helped to drive demand for health and wellness products.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
